While discipline may be the backbone to reaching your fitness goals, motivation is the initial spark that will get things ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

In a world where consumers are increasingly concerned about the quality and safety of the food they consume, studies that ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Patients were randomly assigned to receive either 5 mg/kg intravenous infliximab at weeks 0, 2, and 6 and then every 6-8 ...

Weight loss of 5–10% is associated with improved health in obese individuals; however, currently approved antiobesity drugs typically achieve <5 kg weight ... receive 0.25 mg, 0.5 mg or 1.0 ...

The FDA has granted LBL-034 orphan drug designation for relapsed/refractory multiple myeloma treatment. LBL-034 has received ...

Analyst Andrew Fein from H.C. Wainwright maintained a Buy rating on Dyne Therapeutics (DYN – Research Report) and keeping the price ...

Participants with obesity (a body-mass index [BMI; the weight in kilograms divided by the square ... to receive once-weekly subcutaneous semaglutide (2.4 mg) or placebo, in addition to counseling ...

Scientists at Anand Agricultural University (AAU) in Gujarat, India, have developed a new banana variety called Anand Vaaman.

According to Headline results from part 1 of the phase 3 ESSENCE trial, Semaglutide 2.4 mg may significantly improve liver ...